Abatacept and Etanercept: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Abatacept
Etanercept
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines calm down your immune system. Abatacept (Orencia) and etanercept (a TNF blocker) work in different ways, but they both dial back the same defenses your body uses to fight germs. When you take them together, that protection can get turned down too far.
In studies, using both at once raised the risk of serious infections and did not help people any more than one drug alone. That is why doctors usually do not combine them. The good news is your care team knows about this. If you are switching from one to the other, they will watch you closely for any signs of infection like fever or feeling unwell. Please talk with your doctor or pharmacist before changing anything.
Effect: Additive immunosuppression increasing the risk of serious infection, with no added therapeutic benefit.
- Mechanism: Unknown/additive; both are immunomodulatory biologics (abatacept is a T-cell co-stimulation modulator, etanercept a TNF antagonist). Neither is a prodrug; this is a PD interaction, not PK.
- Direction/magnitude: Increased infection risk; supported by controlled trials of abatacept plus TNF antagonists.
- Evidence: Rated theoretical for mechanism, but clinical outcomes were observed. Onset unspecified.
- Management: Concurrent use is not recommended. When transitioning off a TNF antagonist to abatacept, monitor for signs of infection.
What happens
An increased risk of infection
Interaction Deep Dive
In controlled clinical studies, using abatacept together with tumor necrosis factor (TNF) antagonists was shown to raise the risk of serious infection while offering no extra benefit. Data are inadequate to assess the safety and efficacy of abatacept given alongside anakinra or other biologics used for rheumatoid arthritis or psoriatic arthritis, so combined use of abatacept with these drugs is not advised. Patients switching from TNF antagonist therapy to abatacept should be watched for signs of infection1.
Why it happens (mechanism)
Unknown
How to manage this interaction
The main point: these two are generally not used together. Because both suppress immune activity, combining them raises infection risk without extra benefit.
- Keep taking your medicines exactly as prescribed. Do not stop or change either one on your own.
- If your team is switching you from etanercept to abatacept, expect them to monitor you more closely for signs of infection such as fever, chills, cough, or a wound that will not heal.
- Report any infection symptoms promptly.
- Ask your pharmacist or prescriber to review your full biologic list so your therapy can be individualized safely.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
2 reports — tap to read
a) Taking abatacept together with etanercept provided no added efficacy but raised the risk of serious infection relative to etanercept used alone. In a 1-year, randomized study (N=121) that was followed by an open-label long-term extension (LTE; n=80), rheumatoid arthritis patients who were already receiving etanercept 25 mg twice/week kept taking etanercept and were randomized to receive either abatacept 2 mg/kg IV on days 1, 15, and 30, and then every 4 weeks (n=85) or placebo (n=36). After finishing the double-blind phase, patients could enter the LTE phase, during which the abatacept dose was raised to roughly 10 mg/kg. At 6 months, the 2 mg/kg abatacept group demonstrated no significant improvement over the placebo group in modified American College of Rheumatology 20% (ACR20; 48.2% vs 30.6%) or ACR50 (25.9% vs 19.4%) response rates, but a significant difference was seen in modified ACR70 rates (10.6% vs 0%). At 1 year, no significant differences in ACR20, 50, or 70 response rates were found between the two groups. Serious adverse events occurred more often in the 2 mg/kg abatacept group (16.5%) at one year and in the 10 mg/kg abatacept group after 2 years of LTE (32.5%) than in the placebo group (2.8%). Serious infections at 1 year were reported in 3.5% of the 2 mg/kg abatacept group and 0% of the placebo group 2.
b) In controlled clinical trials involving adults with active rheumatoid arthritis who received abatacept together with a tumor necrosis factor (TNF) antagonist (n=204) compared with TNF antagonist therapy by itself (n=134), the rate of infection (63% vs 43%, respectively) and of serious infection (4.4% vs 0.8%, respectively) was higher with the combined therapy; furthermore, the combined therapy offered no additional benefit 1.
Common questions
Can I take Abatacept and Etanercept together?
Abatacept and etanercept are not recommended together because combining them raises the risk of serious infection with no added benefit; if you are transitioning between them, your care team will watch you closely for infection. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abatacept and Etanercept interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Abatacept and Etanercept interaction managed?
The main point: these two are generally not used together. Because both suppress immune activity, combining them raises infection risk without extra benefit. Keep taking your medicines exactly as prescribed. Do not stop or change either one on your own. If your team is switching you from etanercept to abatacept, expect them to monitor you more closely for signs of infection such as fever, chills,… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Abatacept or Etanercept need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: ORENCIA(R) intravenous, subcutaneous injection, abatacept intravenous, subcutaneous injection. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2020. DailyMed
- Weinblatt M, Schiff M, Goldman A, et al: Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial. Ann Rheum Dis 2007; 66(2):228-234. PubMed
Keep reading about Abatacept
Keep reading about Etanercept
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist